RESEARCH: Maternal Health during and after PMTCT
1077HS: HAART Standard version of the PROMISE Study (Promoting Maternal and Infant Survival Everywhere) (An IMPAACT Study)
BHP049
Principal Investigator: Anthony Ogwu
Funding: NIH
Objectives:
Maternal Health Component: To assess the clinical benefit and safety of continuing vs. stopping HAART used for prevention of MTCT among women who do not require therapy for their own care (CD4 >350 cells/mm3).
Enrollment: July 2010–present